# Efficacy and Safety of Adalimumab Biosimilar GP2017 in Patients with Inflammatory Bowel Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-adalimumab-biosimilar-gp2017-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marta Vernero,Cristina Bezzio,Davide Giuseppe Ribaldone,Stefania Costa,Davide Scalvini,Elisa Tribocco,Gianpiero Manes,Simone Saibeni |
| Citations | 12 |
| DOI | 10.3390/jcm12216839 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.mdpi.com/2077-0383/12/21/6839/pdf?version=1698637123 |
| OpenAlex ID | https://openalex.org/W4388109872 |
| PMID | 37959304 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Davide Scalvini](https://scholariq.org/researchers/davide-scalvini/)

## Paper journal

- [Journal of Clinical Medicine](https://scholariq.org/journals/journal-of-clinical-medicine/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.